Skip to content

Clinical trials

Lupus Erythematosus, Systemic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Clear all

1,178 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20014
200212
200315
200411
200514
200618
200732
200822
200925
201032
201124
201229
201331
201430
201532
201628
201747
201851
201939
202046
202169
202278
202378
2024111
2025128
2026130

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed469
Recruiting233
Unknown status172
Not yet recruiting88
Terminated85
Active, not recruiting67
Withdrawn43
Enrolling by invitation14
Suspended3
No longer available3
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University36
AstraZeneca34
GlaxoSmithKline30
Assistance Publique - Hôpitaux de Paris21
Amgen19
Bristol-Myers Squibb15
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)15
Sohag University14
UCB Pharma14
Duke University13

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic1,178
Autoimmune Diseases128
Lupus Nephritis119
Arthritis, Rheumatoid114
Scleroderma, Systemic97
Sjogren's Syndrome67
Myositis64
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis39
Arthritis36
Connective Tissue Diseases36

Trials

Showing 51 to 75 of 1,178. Each trial links to its page on Pharma Observatory.

1,078 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.